Owner Aegera Therapeutics Inc.

Inventors Boudreault, Alain; Laurent, Alain; Jaquith, James; Bureau, Patrick; Jarvis, Scott

Agent Cullen & Co

Pub. Number AU-A-2007250443

PCT Pub. Number WO2007/131366

Priority 60/879,352 09.01.07 US; 60/800,414 16.05.06 US; 60/833,773 28.07.06 US

Filing date 16 May 2007

Wipo publication date 22 November 2007

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances